Joseph John Dambrauskas, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 722 Sarah Street, Left Front, Carnegie, PA 15106 Phone: 708-262-0004 |
News Archive
As the Ebola Virus Diseases (EVD) epidemic continues to rage in West Africa, infectious diseases experts call attention to the striking lack of treatment guidelines. With over 16,000 total cases and more than 500 new infections reported per week, and probable underreporting of both cases and fatalities, the medical community still does not have specific approved treatment in place for Ebola, according to an editorial published in the International Journal of Infectious Diseases.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, announced that it has reached the targeted enrollment of 105 evaluable patients in its international Phase 2b clinical trial with aldoxorubicin as a first-line treatment for soft tissue sarcoma.
Birdshot uveitis is a rare autoimmune disorder that has the potential to blind. It's notoriously hard to treat.
PBS Newshour: The Newshour Health Unit, in partnership with the Robert Wood Johnson Foundation, explores how doctors in Louisiana "are dealing with the unique challenge of reshaping a health care system that was badly damaged." Dr. Karen DeSalvo, vice dean for Community Affairs and Health Policy at Tulane University, said the response was like creating "health care in the wild. There was nothing."
CVS Caremark reiterated the company's support that the U.S. Food and Drug Administration (FDA) implement regulations necessary to approve biogeneric drugs under the Affordable Care Act. The company's Senior Vice President of Specialty Pharmacy Operations, Scott Reid, testified before the FDA today during a public hearing to address the development of an approval pathway for biosimilar and interchangeable biological products held at the agency's headquarters in Silver Spring, Maryland.
› Verified 4 days ago